Medical Compression Talks on Asset Sale Postponed on FDA Issue

Medical Compression Systems (DBN) Ltd. said talks to sell its DVT assets were postponed until the U.S. Food and Drug Administration responds to answers provided by the company to issues relating to the manufacturing process. Medical Compression expects the FDA response within three months, according to a statement filed today with the Tel Aviv Stock Exchange.

To contact the reporter on this story: Susan Lerner in Jerusalem at

To contact the editor responsible for this story: Alisa Odenheimer at

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.